Assignee
CHONG KUN DANG PHARMACEUTICAL CORP
KR·34 granted patents·30 pending applications·57 citations·filing 2012–2023
Top patents by PatentIndex Score
64 records- 0189US10538498B21,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2016·Granted Jan 21, 2020·7 cites·8 claims
- 0287US10717716B21,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2016·Granted Jul 21, 2020·7 cites·16 claims
- 0386US10464911B21,3,4-oxadiazole sulfamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2016·Granted Nov 5, 2019·7 cites·8 claims
- 0485US10584117B21,3,4-oxadiazole amide derivative compound as histone deacetylase 6 inhibitor, and pharmaceutical composition containing sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2016·Granted Mar 10, 2020·11 cites·8 claims
- 0585US10494355B2Oxadiazole amine derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2016·Granted Dec 3, 2019·7 cites·11 claims
- 0684US12303543B2Composition for preventing or treating gastritis or peptic ulcerCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2023·Granted May 20, 2025·0 cites·1 claims
- 0780US10287255B2Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2015·Granted May 14, 2019·6 cites·8 claims
- 0879US11813285B2Stable pharmaceutical composition comprising esomeprazole and sodium bicarbonateCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2019·Granted Nov 14, 2023·1 cites·4 claims
- 0979US11759428B2Pharmaceutical formulation comprising esomeprazole and sodium bicarbonateCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2019·Granted Sep 19, 2023·1 cites·7 claims
- 1078US11479612B2Anti-c-Met antibody and use thereofCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2018·Granted Oct 25, 2022·2 cites·11 claims
- 1172US9650379B2Azaindole derivatives as selective histone deacetylase (HDAC) inhibitors and pharmaceutical compositions comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2014·Granted May 16, 2017·4 cites·14 claims
- 1271US11958844B21,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2019·Granted Apr 16, 2024·1 cites·9 claims
- 1369US11918618B2Composition for preventing or treating gastritis or peptic ulcerCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2021·Granted Mar 5, 2024·0 cites·5 claims
- 1469US2020054766A1Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the SameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2019·Application pending·0 cites
- 1566US10722585B2Sustained-release lipid pre-concentrate of GNRH analogues and pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2013·Granted Jul 28, 2020·1 cites·24 claims
- 1666US2020061142A1Composition for preventing or treating gastritis or peptic ulcerCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2017·Application pending·0 cites
- 1765US2018271999A1Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the SameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2017·Application pending·0 cites
- 1864US2025214983A11,3,4-oxadiazole triazole compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2023·Application pending·0 cites
- 1962US9878986B2Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2014·Granted Jan 30, 2018·1 cites·7 claims
- 2061US9944600B2Piperidine derivatives for GPR119 agonistCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2013·Granted Apr 17, 2018·1 cites·8 claims
- 2161US2025319093A1Compositions for preventing or treating idiopathic pulmonary fibrosis (ipf)CHONG KUN DANG PHARMACEUTICAL CORP·Filed 2023·Application pending·0 cites
- 2261US2025144109A1Compositions for preventing or treating pulmonary arterial hypertensionCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2023·Application pending·0 cites
- 2361US2025170137A1Compositions for preventing or treating heart failure (HF)CHONG KUN DANG PHARMACEUTICAL CORP·Filed 2023·Application pending·0 cites
- 2460US2026028321A11,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and uses thereofCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2023·Application pending·0 cites
- 2558US2024217978A1COMPOUND AS ADENOSINE A2a RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITION COMPRISING SAMECHONG KUN DANG PHARMACEUTICAL CORP·Filed 2022·Application pending·0 cites
- 2658US2026069688A1Stable antibody compositionCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2023·Application pending·0 cites
- 2756US2024366623A1Compositions for preventing or treating charcot-marie-tooth disease (cmt)CHONG KUN DANG PHARMACEUTICAL CORP·Filed 2022·Application pending·0 cites
- 2855US2024208956A11,3,4-oxadiazole thiocarbonyl compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2022·Application pending·0 cites
- 2955US2024115644A1Composition for preventing, improving or treating gastritis or peptic ulcer comprising extract of cinnamomum cassia, fraction of said extract, isolate of said fraction or compounds isolated therefromCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2021·Application pending·0 cites
- 3054US12570646B2Compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2021·Granted Mar 10, 2026·0 cites·7 claims
- 3154US2023399298A1Acid addition salt of indene derivative prodrug and method for preparing sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2021·Application pending·0 cites
- 3252US12251375B2Pharmaceutical preparation having excellent dissolution properties, containing esomeprazole and sodium bicarbonateCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2019·Granted Mar 18, 2025·0 cites·7 claims
- 3352US2021236468A1Composition for preventing or treating cancer, comprising a vascular disrupting agent and taxane compoundCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2019·Application pending·0 cites
- 3452US2023084129A1Pharmaceutical composition comprising esomeprazole and sodium bicarbonate having excellent release propertiesCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2021·Application pending·0 cites
- 3551US10792285B2Stabilized pharmaceutical composition containing pemetrexed or pharmaceutically acceptable salt thereofCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2016·Granted Oct 6, 2020·0 cites·25 claims
- 3651US2023257372A1Novel compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2021·Application pending·0 cites
- 3750US11318215B2Composition for gene delivery comprising chitosan and liquid crystal formation materialCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2014·Granted May 3, 2022·0 cites·12 claims
- 3850US2023303491A1Donepezil ether palmitate or pharmaceutically acceptable salt thereofCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2021·Application pending·0 cites
- 3950US2022288045A1Stable Pharmaceutical Composition Comprising Esomeprazole And Sodium BicarbonateCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2020·Application pending·0 cites
- 4050US2023248801A1INJECTABLE COMPOSITION COMPRISING GnRH ANALOGUECHONG KUN DANG PHARMACEUTICAL CORP·Filed 2021·Application pending·0 cites
- 4150US2022008414A1Pharmaceutical composition comprising histone deacetylase 6 inhibitorsCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2019·Application pending·0 cites
- 4247US11826460B2Stable pharmaceutical composition comprising testosterone undecanoateCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2019·Granted Nov 28, 2023·0 cites·6 claims
- 4347US11571426B2Compositions for preventing or treating lupusCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2018·Granted Feb 7, 2023·0 cites·6 claims
- 4447US9493430B2Biaryl- or heterocyclic biaryl-substituted cyclohexene derivative compounds as CETP inhibitorsCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2014·Granted Nov 15, 2016·0 cites·10 claims
- 4546US12440484B21,3,4-oxadiazole homophthalimide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2020·Granted Oct 14, 2025·0 cites·9 claims
- 4646US9980953B2Combined composition for preventing or treating cancer comprising a benzophenone thiazole derivatives as a VDA and topoisomerase inhibitorCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2017·Granted May 29, 2018·0 cites·11 claims
- 4746US2023092890A11, 3, 4-Oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2020·Application pending·0 cites
- 4845US2023248735A1Compositions for preventing or treating chronic obstructive pulmonary diseases (copd)CHONG KUN DANG PHARMACEUTICAL CORP·Filed 2020·Application pending·0 cites
- 4944US12522601B21,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2021·Granted Jan 13, 2026·0 cites·13 claims
- 5044US12466827B21,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2021·Granted Nov 11, 2025·0 cites·12 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CHONG KUN DANG PHARMACEUTICAL CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →